4D Molecular Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2020
Total Assets: $288.3M
Liabilities Breakdown FY2020
Total Liabilities: $31.9M
Asset Breakdown
Total Assets: $288.3M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $276.7M | 96.0% |
| Accounts Receivable | $1.5M | 0.5% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $5.1M | 1.8% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $5.0M | 1.8% |
Liabilities Breakdown
Total Liabilities: $31.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.8M | 5.6% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $30.2M | 94.4% |